340B Pharmacy Safeguards Against Rx Diversion, Double Discounts Are Inconsistent – OIG
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Office of Inspector General documents discrepancies among 340B providers in how they ensure contract pharmacies comply with requirements about eligible patients and preventing Medicaid rebates on 340B-discounted drugs. The report will aid HRSA’s development of a comprehensive 340B rule that will address those issues.